nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—CYP2C19—Tamoxifen—pancreatic cancer	0.0804	0.162	CbGbCtD
Bicalutamide—CYP2C9—Tamoxifen—pancreatic cancer	0.0669	0.135	CbGbCtD
Bicalutamide—CYP2D6—Tamoxifen—pancreatic cancer	0.0611	0.123	CbGbCtD
Bicalutamide—CYP2D6—Erlotinib—pancreatic cancer	0.052	0.105	CbGbCtD
Bicalutamide—CYP2C9—Fluorouracil—pancreatic cancer	0.0493	0.0991	CbGbCtD
Bicalutamide—CYP3A4—Tamoxifen—pancreatic cancer	0.0389	0.0782	CbGbCtD
Bicalutamide—CYP3A4—Erlotinib—pancreatic cancer	0.0331	0.0665	CbGbCtD
Bicalutamide—CYP3A4—Irinotecan—pancreatic cancer	0.0299	0.0601	CbGbCtD
Bicalutamide—CYP2D6—Doxorubicin—pancreatic cancer	0.0256	0.0516	CbGbCtD
Bicalutamide—CYP3A4—Docetaxel—pancreatic cancer	0.0219	0.044	CbGbCtD
Bicalutamide—CYP3A4—Sunitinib—pancreatic cancer	0.0218	0.0438	CbGbCtD
Bicalutamide—CYP3A4—Doxorubicin—pancreatic cancer	0.0163	0.0328	CbGbCtD
Bicalutamide—AR—FOXA1 transcription factor network—TFF1—pancreatic cancer	0.000637	0.0536	CbGpPWpGaD
Bicalutamide—AR—Nuclear Receptors—NR5A2—pancreatic cancer	0.0006	0.0505	CbGpPWpGaD
Bicalutamide—AR—Notch-mediated HES/HEY network—RBBP8—pancreatic cancer	0.00048	0.0404	CbGpPWpGaD
Bicalutamide—AR—Nuclear Receptor transcription pathway—NR5A2—pancreatic cancer	0.000474	0.0399	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—BACH1—pancreatic cancer	0.000433	0.0365	CbGpPWpGaD
Bicalutamide—AR—Notch-mediated HES/HEY network—HEY2—pancreatic cancer	0.000359	0.0302	CbGpPWpGaD
Bicalutamide—AR—Notch-mediated HES/HEY network—HEY1—pancreatic cancer	0.000333	0.028	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—GDI1—pancreatic cancer	0.000328	0.0276	CbGpPWpGaD
Bicalutamide—AR—FOXA1 transcription factor network—SHH—pancreatic cancer	0.000292	0.0246	CbGpPWpGaD
Bicalutamide—AR—Androgen receptor signaling pathway—DAXX—pancreatic cancer	0.000263	0.0222	CbGpPWpGaD
Bicalutamide—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.00025	0.00051	CcSEcCtD
Bicalutamide—Vomiting—Sunitinib—pancreatic cancer	0.000249	0.000508	CcSEcCtD
Bicalutamide—Body temperature increased—Gemcitabine—pancreatic cancer	0.000249	0.000507	CcSEcCtD
Bicalutamide—Neutropenia—Epirubicin—pancreatic cancer	0.000248	0.000505	CcSEcCtD
Bicalutamide—Dysuria—Epirubicin—pancreatic cancer	0.000248	0.000505	CcSEcCtD
Bicalutamide—Rash—Sunitinib—pancreatic cancer	0.000247	0.000504	CcSEcCtD
Bicalutamide—Dermatitis—Sunitinib—pancreatic cancer	0.000247	0.000503	CcSEcCtD
Bicalutamide—Urticaria—Fluorouracil—pancreatic cancer	0.000246	0.000501	CcSEcCtD
Bicalutamide—Headache—Sunitinib—pancreatic cancer	0.000246	0.000501	CcSEcCtD
Bicalutamide—Syncope—Docetaxel—pancreatic cancer	0.000246	0.0005	CcSEcCtD
Bicalutamide—Asthma—Doxorubicin—pancreatic cancer	0.000245	0.000499	CcSEcCtD
Bicalutamide—Influenza—Doxorubicin—pancreatic cancer	0.000245	0.000499	CcSEcCtD
Bicalutamide—Dysphagia—Doxorubicin—pancreatic cancer	0.000245	0.000499	CcSEcCtD
Bicalutamide—Pollakiuria—Epirubicin—pancreatic cancer	0.000245	0.000499	CcSEcCtD
Bicalutamide—Body temperature increased—Fluorouracil—pancreatic cancer	0.000245	0.000498	CcSEcCtD
Bicalutamide—Eosinophilia—Doxorubicin—pancreatic cancer	0.000243	0.000495	CcSEcCtD
Bicalutamide—Weight increased—Epirubicin—pancreatic cancer	0.000241	0.000491	CcSEcCtD
Bicalutamide—Loss of consciousness—Docetaxel—pancreatic cancer	0.000241	0.00049	CcSEcCtD
Bicalutamide—Weight decreased—Epirubicin—pancreatic cancer	0.00024	0.000488	CcSEcCtD
Bicalutamide—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000239	0.000487	CcSEcCtD
Bicalutamide—Cough—Docetaxel—pancreatic cancer	0.000239	0.000487	CcSEcCtD
Bicalutamide—Angina pectoris—Doxorubicin—pancreatic cancer	0.000239	0.000487	CcSEcCtD
Bicalutamide—Hypersensitivity—Irinotecan—pancreatic cancer	0.000238	0.000485	CcSEcCtD
Bicalutamide—Pneumonia—Epirubicin—pancreatic cancer	0.000238	0.000484	CcSEcCtD
Bicalutamide—Hypertension—Docetaxel—pancreatic cancer	0.000236	0.000481	CcSEcCtD
Bicalutamide—Bronchitis—Doxorubicin—pancreatic cancer	0.000236	0.00048	CcSEcCtD
Bicalutamide—Myalgia—Docetaxel—pancreatic cancer	0.000233	0.000475	CcSEcCtD
Bicalutamide—Chest pain—Docetaxel—pancreatic cancer	0.000233	0.000475	CcSEcCtD
Bicalutamide—Nausea—Sunitinib—pancreatic cancer	0.000233	0.000475	CcSEcCtD
Bicalutamide—Asthenia—Irinotecan—pancreatic cancer	0.000232	0.000472	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000232	0.000472	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000231	0.000471	CcSEcCtD
Bicalutamide—Jaundice—Epirubicin—pancreatic cancer	0.00023	0.000469	CcSEcCtD
Bicalutamide—Urinary tract infection—Epirubicin—pancreatic cancer	0.00023	0.000468	CcSEcCtD
Bicalutamide—Conjunctivitis—Epirubicin—pancreatic cancer	0.00023	0.000468	CcSEcCtD
Bicalutamide—Neutropenia—Doxorubicin—pancreatic cancer	0.000229	0.000467	CcSEcCtD
Bicalutamide—Dysuria—Doxorubicin—pancreatic cancer	0.000229	0.000467	CcSEcCtD
Bicalutamide—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000228	0.000465	CcSEcCtD
Bicalutamide—Dry mouth—Docetaxel—pancreatic cancer	0.000228	0.000464	CcSEcCtD
Bicalutamide—Sweating—Epirubicin—pancreatic cancer	0.000227	0.000461	CcSEcCtD
Bicalutamide—Pollakiuria—Doxorubicin—pancreatic cancer	0.000227	0.000461	CcSEcCtD
Bicalutamide—AR—FOXA1 transcription factor network—GCG—pancreatic cancer	0.000226	0.019	CbGpPWpGaD
Bicalutamide—Asthenia—Gemcitabine—pancreatic cancer	0.000226	0.00046	CcSEcCtD
Bicalutamide—Haematuria—Epirubicin—pancreatic cancer	0.000225	0.000459	CcSEcCtD
Bicalutamide—Confusional state—Docetaxel—pancreatic cancer	0.000225	0.000459	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000223	0.000455	CcSEcCtD
Bicalutamide—Oedema—Docetaxel—pancreatic cancer	0.000223	0.000455	CcSEcCtD
Bicalutamide—Weight increased—Doxorubicin—pancreatic cancer	0.000223	0.000455	CcSEcCtD
Bicalutamide—Epistaxis—Epirubicin—pancreatic cancer	0.000223	0.000454	CcSEcCtD
Bicalutamide—Pruritus—Gemcitabine—pancreatic cancer	0.000223	0.000454	CcSEcCtD
Bicalutamide—Infection—Docetaxel—pancreatic cancer	0.000222	0.000452	CcSEcCtD
Bicalutamide—Weight decreased—Doxorubicin—pancreatic cancer	0.000222	0.000452	CcSEcCtD
Bicalutamide—Sinusitis—Epirubicin—pancreatic cancer	0.000222	0.000452	CcSEcCtD
Bicalutamide—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000221	0.000451	CcSEcCtD
Bicalutamide—Diarrhoea—Irinotecan—pancreatic cancer	0.000221	0.00045	CcSEcCtD
Bicalutamide—Pneumonia—Doxorubicin—pancreatic cancer	0.00022	0.000448	CcSEcCtD
Bicalutamide—Shock—Docetaxel—pancreatic cancer	0.00022	0.000448	CcSEcCtD
Bicalutamide—Nervous system disorder—Docetaxel—pancreatic cancer	0.000219	0.000446	CcSEcCtD
Bicalutamide—Pruritus—Fluorouracil—pancreatic cancer	0.000219	0.000446	CcSEcCtD
Bicalutamide—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000219	0.000446	CcSEcCtD
Bicalutamide—Skin disorder—Docetaxel—pancreatic cancer	0.000217	0.000442	CcSEcCtD
Bicalutamide—Bradycardia—Epirubicin—pancreatic cancer	0.000216	0.00044	CcSEcCtD
Bicalutamide—Diarrhoea—Gemcitabine—pancreatic cancer	0.000215	0.000439	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000214	0.000437	CcSEcCtD
Bicalutamide—Dizziness—Irinotecan—pancreatic cancer	0.000214	0.000435	CcSEcCtD
Bicalutamide—Haemoglobin—Epirubicin—pancreatic cancer	0.000213	0.000434	CcSEcCtD
Bicalutamide—Jaundice—Doxorubicin—pancreatic cancer	0.000213	0.000434	CcSEcCtD
Bicalutamide—Anorexia—Docetaxel—pancreatic cancer	0.000213	0.000434	CcSEcCtD
Bicalutamide—Rhinitis—Epirubicin—pancreatic cancer	0.000213	0.000433	CcSEcCtD
Bicalutamide—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000213	0.000433	CcSEcCtD
Bicalutamide—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000213	0.000433	CcSEcCtD
Bicalutamide—Haemorrhage—Epirubicin—pancreatic cancer	0.000212	0.000432	CcSEcCtD
Bicalutamide—Diarrhoea—Fluorouracil—pancreatic cancer	0.000212	0.000431	CcSEcCtD
Bicalutamide—Pharyngitis—Epirubicin—pancreatic cancer	0.000211	0.000429	CcSEcCtD
Bicalutamide—Sweating—Doxorubicin—pancreatic cancer	0.00021	0.000427	CcSEcCtD
Bicalutamide—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000209	0.000427	CcSEcCtD
Bicalutamide—Oedema peripheral—Epirubicin—pancreatic cancer	0.000209	0.000426	CcSEcCtD
Bicalutamide—Haematuria—Doxorubicin—pancreatic cancer	0.000208	0.000425	CcSEcCtD
Bicalutamide—Urethral disorder—Epirubicin—pancreatic cancer	0.000208	0.000424	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000207	0.000421	CcSEcCtD
Bicalutamide—Epistaxis—Doxorubicin—pancreatic cancer	0.000206	0.00042	CcSEcCtD
Bicalutamide—Vomiting—Irinotecan—pancreatic cancer	0.000206	0.000419	CcSEcCtD
Bicalutamide—Sinusitis—Doxorubicin—pancreatic cancer	0.000205	0.000418	CcSEcCtD
Bicalutamide—Dizziness—Fluorouracil—pancreatic cancer	0.000205	0.000417	CcSEcCtD
Bicalutamide—Visual impairment—Epirubicin—pancreatic cancer	0.000204	0.000416	CcSEcCtD
Bicalutamide—Rash—Irinotecan—pancreatic cancer	0.000204	0.000415	CcSEcCtD
Bicalutamide—Dermatitis—Irinotecan—pancreatic cancer	0.000204	0.000415	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000204	0.000415	CcSEcCtD
Bicalutamide—Headache—Irinotecan—pancreatic cancer	0.000202	0.000412	CcSEcCtD
Bicalutamide—Insomnia—Docetaxel—pancreatic cancer	0.000202	0.000412	CcSEcCtD
Bicalutamide—Paraesthesia—Docetaxel—pancreatic cancer	0.000201	0.000409	CcSEcCtD
Bicalutamide—Vomiting—Gemcitabine—pancreatic cancer	0.0002	0.000408	CcSEcCtD
Bicalutamide—Bradycardia—Doxorubicin—pancreatic cancer	0.0002	0.000407	CcSEcCtD
Bicalutamide—Dyspnoea—Docetaxel—pancreatic cancer	0.000199	0.000406	CcSEcCtD
Bicalutamide—Somnolence—Docetaxel—pancreatic cancer	0.000199	0.000405	CcSEcCtD
Bicalutamide—Rash—Gemcitabine—pancreatic cancer	0.000199	0.000404	CcSEcCtD
Bicalutamide—Dermatitis—Gemcitabine—pancreatic cancer	0.000198	0.000404	CcSEcCtD
Bicalutamide—Haemoglobin—Doxorubicin—pancreatic cancer	0.000197	0.000402	CcSEcCtD
Bicalutamide—Headache—Gemcitabine—pancreatic cancer	0.000197	0.000402	CcSEcCtD
Bicalutamide—Cardiac disorder—Epirubicin—pancreatic cancer	0.000197	0.000401	CcSEcCtD
Bicalutamide—Vomiting—Fluorouracil—pancreatic cancer	0.000197	0.000401	CcSEcCtD
Bicalutamide—Rhinitis—Doxorubicin—pancreatic cancer	0.000197	0.000401	CcSEcCtD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.000197	0.0166	CbGpPWpGaD
Bicalutamide—Dyspepsia—Docetaxel—pancreatic cancer	0.000197	0.000401	CcSEcCtD
Bicalutamide—Haemorrhage—Doxorubicin—pancreatic cancer	0.000196	0.0004	CcSEcCtD
Bicalutamide—Rash—Fluorouracil—pancreatic cancer	0.000195	0.000398	CcSEcCtD
Bicalutamide—Dermatitis—Fluorouracil—pancreatic cancer	0.000195	0.000397	CcSEcCtD
Bicalutamide—Pharyngitis—Doxorubicin—pancreatic cancer	0.000195	0.000397	CcSEcCtD
Bicalutamide—Decreased appetite—Docetaxel—pancreatic cancer	0.000194	0.000396	CcSEcCtD
Bicalutamide—Headache—Fluorouracil—pancreatic cancer	0.000194	0.000395	CcSEcCtD
Bicalutamide—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000194	0.000395	CcSEcCtD
Bicalutamide—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000193	0.000394	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000193	0.000393	CcSEcCtD
Bicalutamide—Fatigue—Docetaxel—pancreatic cancer	0.000193	0.000392	CcSEcCtD
Bicalutamide—Angiopathy—Epirubicin—pancreatic cancer	0.000192	0.000392	CcSEcCtD
Bicalutamide—Urethral disorder—Doxorubicin—pancreatic cancer	0.000192	0.000392	CcSEcCtD
Bicalutamide—Nausea—Irinotecan—pancreatic cancer	0.000192	0.000391	CcSEcCtD
Bicalutamide—Immune system disorder—Epirubicin—pancreatic cancer	0.000192	0.00039	CcSEcCtD
Bicalutamide—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000191	0.000389	CcSEcCtD
Bicalutamide—Constipation—Docetaxel—pancreatic cancer	0.000191	0.000389	CcSEcCtD
Bicalutamide—Pain—Docetaxel—pancreatic cancer	0.000191	0.000389	CcSEcCtD
Bicalutamide—Chills—Epirubicin—pancreatic cancer	0.00019	0.000388	CcSEcCtD
Bicalutamide—Arrhythmia—Epirubicin—pancreatic cancer	0.00019	0.000386	CcSEcCtD
Bicalutamide—Visual impairment—Doxorubicin—pancreatic cancer	0.000189	0.000385	CcSEcCtD
Bicalutamide—Alopecia—Epirubicin—pancreatic cancer	0.000187	0.000382	CcSEcCtD
Bicalutamide—Nausea—Gemcitabine—pancreatic cancer	0.000187	0.000381	CcSEcCtD
Bicalutamide—Mental disorder—Epirubicin—pancreatic cancer	0.000186	0.000379	CcSEcCtD
Bicalutamide—Malnutrition—Epirubicin—pancreatic cancer	0.000185	0.000376	CcSEcCtD
Bicalutamide—Feeling abnormal—Docetaxel—pancreatic cancer	0.000184	0.000375	CcSEcCtD
Bicalutamide—Nausea—Fluorouracil—pancreatic cancer	0.000184	0.000375	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000183	0.000372	CcSEcCtD
Bicalutamide—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000182	0.000371	CcSEcCtD
Bicalutamide—Flatulence—Epirubicin—pancreatic cancer	0.000182	0.000371	CcSEcCtD
Bicalutamide—Tension—Epirubicin—pancreatic cancer	0.000181	0.000369	CcSEcCtD
Bicalutamide—Nervousness—Epirubicin—pancreatic cancer	0.000179	0.000365	CcSEcCtD
Bicalutamide—Back pain—Epirubicin—pancreatic cancer	0.000179	0.000364	CcSEcCtD
Bicalutamide—Angiopathy—Doxorubicin—pancreatic cancer	0.000178	0.000363	CcSEcCtD
Bicalutamide—Muscle spasms—Epirubicin—pancreatic cancer	0.000178	0.000362	CcSEcCtD
Bicalutamide—Immune system disorder—Doxorubicin—pancreatic cancer	0.000177	0.000361	CcSEcCtD
Bicalutamide—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000177	0.00036	CcSEcCtD
Bicalutamide—Body temperature increased—Docetaxel—pancreatic cancer	0.000177	0.00036	CcSEcCtD
Bicalutamide—Abdominal pain—Docetaxel—pancreatic cancer	0.000177	0.00036	CcSEcCtD
Bicalutamide—Chills—Doxorubicin—pancreatic cancer	0.000176	0.000359	CcSEcCtD
Bicalutamide—Arrhythmia—Doxorubicin—pancreatic cancer	0.000175	0.000357	CcSEcCtD
Bicalutamide—Alopecia—Doxorubicin—pancreatic cancer	0.000173	0.000353	CcSEcCtD
Bicalutamide—AR—Notch-mediated HES/HEY network—HES1—pancreatic cancer	0.000172	0.0145	CbGpPWpGaD
Bicalutamide—Mental disorder—Doxorubicin—pancreatic cancer	0.000172	0.00035	CcSEcCtD
Bicalutamide—Malnutrition—Doxorubicin—pancreatic cancer	0.000171	0.000348	CcSEcCtD
Bicalutamide—Anaemia—Epirubicin—pancreatic cancer	0.000171	0.000348	CcSEcCtD
Bicalutamide—Flatulence—Doxorubicin—pancreatic cancer	0.000168	0.000343	CcSEcCtD
Bicalutamide—AR—SIDS Susceptibility Pathways—SSTR1—pancreatic cancer	0.000168	0.0141	CbGpPWpGaD
Bicalutamide—Tension—Doxorubicin—pancreatic cancer	0.000168	0.000342	CcSEcCtD
Bicalutamide—Nervousness—Doxorubicin—pancreatic cancer	0.000166	0.000338	CcSEcCtD
Bicalutamide—Syncope—Epirubicin—pancreatic cancer	0.000166	0.000337	CcSEcCtD
Bicalutamide—Back pain—Doxorubicin—pancreatic cancer	0.000165	0.000337	CcSEcCtD
Bicalutamide—Hypersensitivity—Docetaxel—pancreatic cancer	0.000165	0.000335	CcSEcCtD
Bicalutamide—Muscle spasms—Doxorubicin—pancreatic cancer	0.000164	0.000335	CcSEcCtD
Bicalutamide—Loss of consciousness—Epirubicin—pancreatic cancer	0.000162	0.000331	CcSEcCtD
Bicalutamide—AR—SIDS Susceptibility Pathways—SSTR2—pancreatic cancer	0.000162	0.0136	CbGpPWpGaD
Bicalutamide—Cough—Epirubicin—pancreatic cancer	0.000161	0.000328	CcSEcCtD
Bicalutamide—Asthenia—Docetaxel—pancreatic cancer	0.00016	0.000327	CcSEcCtD
Bicalutamide—Hypertension—Epirubicin—pancreatic cancer	0.000159	0.000325	CcSEcCtD
Bicalutamide—Pruritus—Docetaxel—pancreatic cancer	0.000158	0.000322	CcSEcCtD
Bicalutamide—Anaemia—Doxorubicin—pancreatic cancer	0.000158	0.000322	CcSEcCtD
Bicalutamide—Myalgia—Epirubicin—pancreatic cancer	0.000157	0.00032	CcSEcCtD
Bicalutamide—Chest pain—Epirubicin—pancreatic cancer	0.000157	0.00032	CcSEcCtD
Bicalutamide—Anxiety—Epirubicin—pancreatic cancer	0.000157	0.000319	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000156	0.000318	CcSEcCtD
Bicalutamide—Dry mouth—Epirubicin—pancreatic cancer	0.000154	0.000313	CcSEcCtD
Bicalutamide—Syncope—Doxorubicin—pancreatic cancer	0.000153	0.000312	CcSEcCtD
Bicalutamide—Diarrhoea—Docetaxel—pancreatic cancer	0.000153	0.000311	CcSEcCtD
Bicalutamide—Confusional state—Epirubicin—pancreatic cancer	0.000152	0.00031	CcSEcCtD
Bicalutamide—Oedema—Epirubicin—pancreatic cancer	0.000151	0.000307	CcSEcCtD
Bicalutamide—Loss of consciousness—Doxorubicin—pancreatic cancer	0.00015	0.000306	CcSEcCtD
Bicalutamide—Infection—Epirubicin—pancreatic cancer	0.00015	0.000305	CcSEcCtD
Bicalutamide—Cough—Doxorubicin—pancreatic cancer	0.000149	0.000304	CcSEcCtD
Bicalutamide—Shock—Epirubicin—pancreatic cancer	0.000148	0.000302	CcSEcCtD
Bicalutamide—Nervous system disorder—Epirubicin—pancreatic cancer	0.000148	0.000301	CcSEcCtD
Bicalutamide—Dizziness—Docetaxel—pancreatic cancer	0.000148	0.000301	CcSEcCtD
Bicalutamide—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000148	0.000301	CcSEcCtD
Bicalutamide—Hypertension—Doxorubicin—pancreatic cancer	0.000148	0.0003	CcSEcCtD
Bicalutamide—Skin disorder—Epirubicin—pancreatic cancer	0.000146	0.000298	CcSEcCtD
Bicalutamide—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000146	0.000297	CcSEcCtD
Bicalutamide—AR—Nuclear Receptors—PPARG—pancreatic cancer	0.000146	0.0122	CbGpPWpGaD
Bicalutamide—Myalgia—Doxorubicin—pancreatic cancer	0.000145	0.000296	CcSEcCtD
Bicalutamide—Chest pain—Doxorubicin—pancreatic cancer	0.000145	0.000296	CcSEcCtD
Bicalutamide—Anxiety—Doxorubicin—pancreatic cancer	0.000145	0.000295	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000144	0.000294	CcSEcCtD
Bicalutamide—AR—Notch-mediated HES/HEY network—HIF1A—pancreatic cancer	0.000144	0.0121	CbGpPWpGaD
Bicalutamide—Anorexia—Epirubicin—pancreatic cancer	0.000144	0.000293	CcSEcCtD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.000143	0.012	CbGpPWpGaD
Bicalutamide—Dry mouth—Doxorubicin—pancreatic cancer	0.000142	0.00029	CcSEcCtD
Bicalutamide—Vomiting—Docetaxel—pancreatic cancer	0.000142	0.000289	CcSEcCtD
Bicalutamide—Rash—Docetaxel—pancreatic cancer	0.000141	0.000287	CcSEcCtD
Bicalutamide—Dermatitis—Docetaxel—pancreatic cancer	0.000141	0.000287	CcSEcCtD
Bicalutamide—Confusional state—Doxorubicin—pancreatic cancer	0.000141	0.000286	CcSEcCtD
Bicalutamide—Headache—Docetaxel—pancreatic cancer	0.00014	0.000285	CcSEcCtD
Bicalutamide—Oedema—Doxorubicin—pancreatic cancer	0.000139	0.000284	CcSEcCtD
Bicalutamide—Infection—Doxorubicin—pancreatic cancer	0.000139	0.000282	CcSEcCtD
Bicalutamide—AR—Notch-mediated HES/HEY network—KDR—pancreatic cancer	0.000138	0.0116	CbGpPWpGaD
Bicalutamide—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000137	0.00028	CcSEcCtD
Bicalutamide—Shock—Doxorubicin—pancreatic cancer	0.000137	0.000279	CcSEcCtD
Bicalutamide—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000137	0.000279	CcSEcCtD
Bicalutamide—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000137	0.000278	CcSEcCtD
Bicalutamide—Insomnia—Epirubicin—pancreatic cancer	0.000136	0.000278	CcSEcCtD
Bicalutamide—Skin disorder—Doxorubicin—pancreatic cancer	0.000135	0.000276	CcSEcCtD
Bicalutamide—Paraesthesia—Epirubicin—pancreatic cancer	0.000135	0.000276	CcSEcCtD
Bicalutamide—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000135	0.000275	CcSEcCtD
Bicalutamide—Dyspnoea—Epirubicin—pancreatic cancer	0.000134	0.000274	CcSEcCtD
Bicalutamide—Somnolence—Epirubicin—pancreatic cancer	0.000134	0.000273	CcSEcCtD
Bicalutamide—Anorexia—Doxorubicin—pancreatic cancer	0.000133	0.000271	CcSEcCtD
Bicalutamide—Nausea—Docetaxel—pancreatic cancer	0.000133	0.00027	CcSEcCtD
Bicalutamide—Dyspepsia—Epirubicin—pancreatic cancer	0.000133	0.00027	CcSEcCtD
Bicalutamide—Decreased appetite—Epirubicin—pancreatic cancer	0.000131	0.000267	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00013	0.000265	CcSEcCtD
Bicalutamide—AR—Notch-mediated HES/HEY network—NOTCH1—pancreatic cancer	0.00013	0.0109	CbGpPWpGaD
Bicalutamide—Fatigue—Epirubicin—pancreatic cancer	0.00013	0.000265	CcSEcCtD
Bicalutamide—Pain—Epirubicin—pancreatic cancer	0.000129	0.000262	CcSEcCtD
Bicalutamide—Constipation—Epirubicin—pancreatic cancer	0.000129	0.000262	CcSEcCtD
Bicalutamide—AR—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	0.000127	0.0107	CbGpPWpGaD
Bicalutamide—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000127	0.000259	CcSEcCtD
Bicalutamide—Insomnia—Doxorubicin—pancreatic cancer	0.000126	0.000257	CcSEcCtD
Bicalutamide—Paraesthesia—Doxorubicin—pancreatic cancer	0.000125	0.000255	CcSEcCtD
Bicalutamide—AR—Integrated Breast Cancer Pathway—AHR—pancreatic cancer	0.000125	0.0105	CbGpPWpGaD
Bicalutamide—Dyspnoea—Doxorubicin—pancreatic cancer	0.000124	0.000253	CcSEcCtD
Bicalutamide—Feeling abnormal—Epirubicin—pancreatic cancer	0.000124	0.000253	CcSEcCtD
Bicalutamide—Somnolence—Doxorubicin—pancreatic cancer	0.000124	0.000252	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000123	0.000251	CcSEcCtD
Bicalutamide—Dyspepsia—Doxorubicin—pancreatic cancer	0.000123	0.00025	CcSEcCtD
Bicalutamide—Decreased appetite—Doxorubicin—pancreatic cancer	0.000121	0.000247	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00012	0.000245	CcSEcCtD
Bicalutamide—Fatigue—Doxorubicin—pancreatic cancer	0.00012	0.000245	CcSEcCtD
Bicalutamide—Urticaria—Epirubicin—pancreatic cancer	0.00012	0.000244	CcSEcCtD
Bicalutamide—Pain—Doxorubicin—pancreatic cancer	0.000119	0.000243	CcSEcCtD
Bicalutamide—Constipation—Doxorubicin—pancreatic cancer	0.000119	0.000243	CcSEcCtD
Bicalutamide—Body temperature increased—Epirubicin—pancreatic cancer	0.000119	0.000243	CcSEcCtD
Bicalutamide—Abdominal pain—Epirubicin—pancreatic cancer	0.000119	0.000243	CcSEcCtD
Bicalutamide—AR—Notch-mediated HES/HEY network—RB1—pancreatic cancer	0.000118	0.00989	CbGpPWpGaD
Bicalutamide—AR—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.000115	0.00968	CbGpPWpGaD
Bicalutamide—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000115	0.000234	CcSEcCtD
Bicalutamide—AR—Regulation of nuclear SMAD2/3 signaling—SMAD4—pancreatic cancer	0.000114	0.00961	CbGpPWpGaD
Bicalutamide—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000114	0.000232	CcSEcCtD
Bicalutamide—Hypersensitivity—Epirubicin—pancreatic cancer	0.000111	0.000226	CcSEcCtD
Bicalutamide—Urticaria—Doxorubicin—pancreatic cancer	0.000111	0.000226	CcSEcCtD
Bicalutamide—Abdominal pain—Doxorubicin—pancreatic cancer	0.00011	0.000225	CcSEcCtD
Bicalutamide—Body temperature increased—Doxorubicin—pancreatic cancer	0.00011	0.000225	CcSEcCtD
Bicalutamide—AR—Nongenotropic Androgen signaling—SRC—pancreatic cancer	0.000109	0.00917	CbGpPWpGaD
Bicalutamide—Asthenia—Epirubicin—pancreatic cancer	0.000108	0.00022	CcSEcCtD
Bicalutamide—Pruritus—Epirubicin—pancreatic cancer	0.000107	0.000217	CcSEcCtD
Bicalutamide—AR—Androgen receptor signaling pathway—SMAD4—pancreatic cancer	0.000106	0.00891	CbGpPWpGaD
Bicalutamide—Diarrhoea—Epirubicin—pancreatic cancer	0.000103	0.00021	CcSEcCtD
Bicalutamide—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000103	0.000209	CcSEcCtD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.000101	0.00847	CbGpPWpGaD
Bicalutamide—Asthenia—Doxorubicin—pancreatic cancer	0.0001	0.000204	CcSEcCtD
Bicalutamide—Dizziness—Epirubicin—pancreatic cancer	9.97e-05	0.000203	CcSEcCtD
Bicalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—pancreatic cancer	9.87e-05	0.0083	CbGpPWpGaD
Bicalutamide—Pruritus—Doxorubicin—pancreatic cancer	9.87e-05	0.000201	CcSEcCtD
Bicalutamide—Vomiting—Epirubicin—pancreatic cancer	9.58e-05	0.000195	CcSEcCtD
Bicalutamide—Diarrhoea—Doxorubicin—pancreatic cancer	9.54e-05	0.000194	CcSEcCtD
Bicalutamide—Rash—Epirubicin—pancreatic cancer	9.5e-05	0.000194	CcSEcCtD
Bicalutamide—Dermatitis—Epirubicin—pancreatic cancer	9.49e-05	0.000193	CcSEcCtD
Bicalutamide—Headache—Epirubicin—pancreatic cancer	9.44e-05	0.000192	CcSEcCtD
Bicalutamide—AR—Integrated Breast Cancer Pathway—GADD45A—pancreatic cancer	9.25e-05	0.00778	CbGpPWpGaD
Bicalutamide—Dizziness—Doxorubicin—pancreatic cancer	9.22e-05	0.000188	CcSEcCtD
Bicalutamide—AR—SIDS Susceptibility Pathways—SST—pancreatic cancer	9.21e-05	0.00775	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	9.03e-05	0.0076	CbGpPWpGaD
Bicalutamide—Nausea—Epirubicin—pancreatic cancer	8.95e-05	0.000182	CcSEcCtD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	8.92e-05	0.00751	CbGpPWpGaD
Bicalutamide—Vomiting—Doxorubicin—pancreatic cancer	8.87e-05	0.000181	CcSEcCtD
Bicalutamide—Rash—Doxorubicin—pancreatic cancer	8.79e-05	0.000179	CcSEcCtD
Bicalutamide—Dermatitis—Doxorubicin—pancreatic cancer	8.78e-05	0.000179	CcSEcCtD
Bicalutamide—Headache—Doxorubicin—pancreatic cancer	8.74e-05	0.000178	CcSEcCtD
Bicalutamide—CYP2C19—Melatonin metabolism and effects—APOE—pancreatic cancer	8.66e-05	0.00729	CbGpPWpGaD
Bicalutamide—AR—Coregulation of Androgen receptor activity—CDKN2A—pancreatic cancer	8.39e-05	0.00706	CbGpPWpGaD
Bicalutamide—AR—Nongenotropic Androgen signaling—PIK3CA—pancreatic cancer	8.29e-05	0.00698	CbGpPWpGaD
Bicalutamide—Nausea—Doxorubicin—pancreatic cancer	8.28e-05	0.000169	CcSEcCtD
Bicalutamide—AR—Generic Transcription Pathway—NR5A2—pancreatic cancer	8.19e-05	0.00689	CbGpPWpGaD
Bicalutamide—CYP2D6—Melatonin metabolism and effects—APOE—pancreatic cancer	7.97e-05	0.0067	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—STK11—pancreatic cancer	7.92e-05	0.00666	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	7.8e-05	0.00656	CbGpPWpGaD
Bicalutamide—AR—Nongenotropic Androgen signaling—HRAS—pancreatic cancer	7.67e-05	0.00645	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	7.67e-05	0.00645	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—pancreatic cancer	7.65e-05	0.00644	CbGpPWpGaD
Bicalutamide—AR—Notch-mediated HES/HEY network—STAT3—pancreatic cancer	7.53e-05	0.00634	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—pancreatic cancer	7.37e-05	0.0062	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—BRCA2—pancreatic cancer	7.16e-05	0.00603	CbGpPWpGaD
Bicalutamide—AR—Regulation of Androgen receptor activity—SRC—pancreatic cancer	7.1e-05	0.00597	CbGpPWpGaD
Bicalutamide—AR—Coregulation of Androgen receptor activity—CCND1—pancreatic cancer	7.08e-05	0.00596	CbGpPWpGaD
Bicalutamide—AR—Androgen receptor signaling pathway—RB1—pancreatic cancer	7.05e-05	0.00593	CbGpPWpGaD
Bicalutamide—AR—Coregulation of Androgen receptor activity—CTNNB1—pancreatic cancer	7.02e-05	0.0059	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—SMAD4—pancreatic cancer	6.94e-05	0.00584	CbGpPWpGaD
Bicalutamide—AR—Nongenotropic Androgen signaling—AKT1—pancreatic cancer	6.77e-05	0.0057	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—pancreatic cancer	6.75e-05	0.00568	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—HES1—pancreatic cancer	6.6e-05	0.00555	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	6.56e-05	0.00552	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—pancreatic cancer	6.12e-05	0.00515	CbGpPWpGaD
Bicalutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	6.06e-05	0.0051	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	5.94e-05	0.00499	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	5.75e-05	0.00484	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—pancreatic cancer	5.7e-05	0.0048	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—TSC2—pancreatic cancer	5.66e-05	0.00476	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—pancreatic cancer	5.65e-05	0.00475	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	5.65e-05	0.00475	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—pancreatic cancer	5.54e-05	0.00466	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	5.53e-05	0.00465	CbGpPWpGaD
Bicalutamide—AR—Androgen receptor signaling pathway—CCND1—pancreatic cancer	5.24e-05	0.00441	CbGpPWpGaD
Bicalutamide—AR—Androgen receptor signaling pathway—CTNNB1—pancreatic cancer	5.19e-05	0.00436	CbGpPWpGaD
Bicalutamide—AR—Androgen receptor signaling pathway—PTEN—pancreatic cancer	5.05e-05	0.00425	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—CHD3—pancreatic cancer	4.71e-05	0.00396	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—MEN1—pancreatic cancer	4.7e-05	0.00396	CbGpPWpGaD
Bicalutamide—AR—Androgen receptor signaling pathway—SRC—pancreatic cancer	4.69e-05	0.00394	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—RB1—pancreatic cancer	4.62e-05	0.00389	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—CDH1—pancreatic cancer	4.6e-05	0.00387	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—pancreatic cancer	4.57e-05	0.00385	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	4.53e-05	0.00381	CbGpPWpGaD
Bicalutamide—AR—Androgen receptor signaling pathway—STAT3—pancreatic cancer	4.52e-05	0.0038	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—NOTCH4—pancreatic cancer	4.46e-05	0.00375	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	4.28e-05	0.0036	CbGpPWpGaD
Bicalutamide—AR—Androgen receptor signaling pathway—EGFR—pancreatic cancer	4.11e-05	0.00346	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	4.1e-05	0.00345	CbGpPWpGaD
Bicalutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	4e-05	0.00336	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—NR5A2—pancreatic cancer	3.94e-05	0.00332	CbGpPWpGaD
Bicalutamide—AR—Coregulation of Androgen receptor activity—AKT1—pancreatic cancer	3.94e-05	0.00332	CbGpPWpGaD
Bicalutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—pancreatic cancer	3.84e-05	0.00323	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—NOTCH3—pancreatic cancer	3.79e-05	0.00319	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	3.59e-05	0.00302	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—CASP3—pancreatic cancer	3.52e-05	0.00297	CbGpPWpGaD
Bicalutamide—CYP2C9—Arachidonic acid metabolism—PTGS2—pancreatic cancer	3.5e-05	0.00294	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	3.43e-05	0.00289	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—CCND1—pancreatic cancer	3.43e-05	0.00289	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—CTNNB1—pancreatic cancer	3.4e-05	0.00286	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—PTEN—pancreatic cancer	3.31e-05	0.00279	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	3.31e-05	0.00278	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	3.15e-05	0.00265	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	3.14e-05	0.00264	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	2.99e-05	0.00252	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	2.92e-05	0.00246	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	2.91e-05	0.00245	CbGpPWpGaD
Bicalutamide—AR—Androgen receptor signaling pathway—AKT1—pancreatic cancer	2.91e-05	0.00245	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—SMAD4—pancreatic cancer	2.86e-05	0.0024	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	2.84e-05	0.00239	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	2.82e-05	0.00237	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	2.75e-05	0.00232	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	2.74e-05	0.00231	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	2.69e-05	0.00226	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.54e-05	0.00214	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	2.54e-05	0.00214	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—TNF—pancreatic cancer	2.5e-05	0.0021	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2.48e-05	0.00209	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	2.28e-05	0.00192	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	2.27e-05	0.00191	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—MEN1—pancreatic cancer	2.26e-05	0.00191	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	2.26e-05	0.0019	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	2.23e-05	0.00188	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—NOTCH4—pancreatic cancer	2.15e-05	0.00181	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	2.12e-05	0.00179	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	2.11e-05	0.00177	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—NOTCH1—pancreatic cancer	2.11e-05	0.00177	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—HSPA1B—pancreatic cancer	2.05e-05	0.00172	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—PPARG—pancreatic cancer	1.99e-05	0.00167	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.94e-05	0.00163	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	1.91e-05	0.00161	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.87e-05	0.00158	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—EZH2—pancreatic cancer	1.87e-05	0.00157	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—NOTCH3—pancreatic cancer	1.83e-05	0.00154	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—HSPA1A—pancreatic cancer	1.73e-05	0.00145	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.58e-05	0.00133	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—SMAD4—pancreatic cancer	1.37e-05	0.00116	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PRSS1—pancreatic cancer	1.28e-05	0.00108	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PRSS1—pancreatic cancer	1.18e-05	0.000991	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PRSS1—pancreatic cancer	1.17e-05	0.000982	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—MYC—pancreatic cancer	1.13e-05	0.000953	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ARG2—pancreatic cancer	1.11e-05	0.000934	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ARG2—pancreatic cancer	1.02e-05	0.000859	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—NOTCH1—pancreatic cancer	1.01e-05	0.000853	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ARG2—pancreatic cancer	1.01e-05	0.000852	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—TYMP—pancreatic cancer	9.7e-06	0.000816	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—PPARG—pancreatic cancer	9.57e-06	0.000805	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—TYMP—pancreatic cancer	8.92e-06	0.000751	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—TYMP—pancreatic cancer	8.85e-06	0.000744	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	8.01e-06	0.000674	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GLP1R—pancreatic cancer	7.82e-06	0.000658	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PRSS1—pancreatic cancer	7.7e-06	0.000648	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—DPYD—pancreatic cancer	7.69e-06	0.000647	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	7.3e-06	0.000614	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	7.3e-06	0.000614	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.23e-06	0.000608	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GLP1R—pancreatic cancer	7.19e-06	0.000605	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GLP1R—pancreatic cancer	7.13e-06	0.0006	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—DPYD—pancreatic cancer	7.08e-06	0.000595	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—DPYD—pancreatic cancer	7.02e-06	0.00059	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.97e-06	0.000587	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	6.72e-06	0.000565	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ARG2—pancreatic cancer	6.68e-06	0.000562	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	6.66e-06	0.00056	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.59e-06	0.000554	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.36e-06	0.000535	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.35e-06	0.000534	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—TYMP—pancreatic cancer	5.84e-06	0.000491	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.79e-06	0.000487	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CD44—pancreatic cancer	5.65e-06	0.000476	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.54e-06	0.000466	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.49e-06	0.000462	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—MYC—pancreatic cancer	5.45e-06	0.000459	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GCG—pancreatic cancer	5.42e-06	0.000456	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CD44—pancreatic cancer	5.2e-06	0.000438	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CD44—pancreatic cancer	5.16e-06	0.000434	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—STK11—pancreatic cancer	5.1e-06	0.000429	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.05e-06	0.000425	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5e-06	0.000421	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GCG—pancreatic cancer	4.99e-06	0.00042	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GCG—pancreatic cancer	4.94e-06	0.000416	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.78e-06	0.000403	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GLP1R—pancreatic cancer	4.7e-06	0.000396	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—STK11—pancreatic cancer	4.69e-06	0.000394	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—STK11—pancreatic cancer	4.65e-06	0.000391	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—DPYD—pancreatic cancer	4.63e-06	0.000389	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	4.39e-06	0.000369	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—TYMS—pancreatic cancer	4.38e-06	0.000369	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.36e-06	0.000367	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—TYMS—pancreatic cancer	4.03e-06	0.000339	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—TYMS—pancreatic cancer	4e-06	0.000336	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—AKT1—pancreatic cancer	3.78e-06	0.000318	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—APOE—pancreatic cancer	3.57e-06	0.0003	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CD44—pancreatic cancer	3.4e-06	0.000286	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.38e-06	0.000284	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—APOE—pancreatic cancer	3.28e-06	0.000276	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GCG—pancreatic cancer	3.26e-06	0.000274	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—APOE—pancreatic cancer	3.25e-06	0.000274	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	3.22e-06	0.000271	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PPARG—pancreatic cancer	3.11e-06	0.000261	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.08e-06	0.000259	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—STK11—pancreatic cancer	3.07e-06	0.000258	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	2.96e-06	0.000249	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	2.93e-06	0.000247	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PPARG—pancreatic cancer	2.86e-06	0.00024	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PPARG—pancreatic cancer	2.83e-06	0.000238	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	2.83e-06	0.000238	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—TYMS—pancreatic cancer	2.64e-06	0.000222	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	2.6e-06	0.000219	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	2.58e-06	0.000217	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	2.47e-06	0.000207	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PTGS2—pancreatic cancer	2.44e-06	0.000206	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	2.27e-06	0.000191	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	2.25e-06	0.000189	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.25e-06	0.000189	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PTGS2—pancreatic cancer	2.23e-06	0.000187	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—APOE—pancreatic cancer	2.14e-06	0.00018	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PTEN—pancreatic cancer	2.13e-06	0.000179	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.96e-06	0.000165	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.94e-06	0.000163	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.94e-06	0.000163	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.87e-06	0.000157	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.7e-06	0.000143	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.5e-06	0.000126	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.48e-06	0.000125	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.47e-06	0.000124	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.38e-06	0.000116	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.37e-06	0.000115	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.28e-06	0.000108	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.23e-06	0.000103	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.13e-06	9.5e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.12e-06	9.42e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	9.04e-07	7.61e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—AKT1—pancreatic cancer	7.38e-07	6.21e-05	CbGpPWpGaD
